TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ABT

Abbott Laboratories

Healthcare · Medical Devices

103.50$ -0.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 12,593 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement ABT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
5,302 5,333 6,335 6,637 6,829 7,589 7,390 7,767 7,656 7,765 7,535 7,979 8,076 8,314 7,726 7,328 8,853 10,701 10,456 10,223 10,928 11,468 11,895 11,257 10,410 10,091 9,747 9,978 10,143 10,241 9,964 10,377 10,635 10,974 10,358 11,142 11,369 11,459 11,164 12,593 46,585
2,430 2,416 3,561 3,579 3,351 3,808 3,611 3,790 3,672 3,682 3,645 3,779 3,866 3,931 3,849 3,847 4,521 5,014 4,886 4,848 4,868 5,259 5,526 5,483 5,201 5,120 4,942 5,033 5,109 4,983 4,942 5,072 5,209 5,376 4,914 4,854 5,031 4,922 4,881 5,289 20,123
2,872 2,917 2,774 3,058 3,478 3,781 3,779 3,977 3,984 4,083 3,890 4,200 4,210 4,383 3,877 3,481 4,332 5,687 5,570 5,375 6,060 6,209 6,369 5,774 5,209 4,971 4,805 4,945 5,034 5,258 5,022 5,305 5,426 5,598 5,444 6,288 6,338 6,537 6,283 7,304 26,462
336 338 541 520 493 618 581 573 573 561 670 577 594 575 576 564 580 698 654 654 672 758 697 684 780 691 654 710 661 690 683 697 713 728 703 732 785 735 756 882 3,158
1,628 1,609 2,424 2,132 2,099 2,462 2,542 2,466 2,377 2,359 2,478 2,434 2,440 2,413 2,548 2,276 2,302 2,553 2,783 2,790 2,737 3,048 2,787 2,757 2,692 2,829 2,760 2,740 2,680 2,724 2,959 2,936 2,895 2,907 3,061 3,090 3,051 3,129 3,740 – –
1,954 1,942 2,840 2,670 2,573 3,046 3,108 3,030 2,934 2,907 3,131 3,010 3,008 2,978 3,098 2,839 2,876 3,273 3,437 3,377 3,438 3,762 3,484 3,441 3,506 3,530 3,405 3,434 3,356 3,394 3,637 3,619 3,608 3,608 3,756 4,236 4,308 4,286 4,441 5,522 18,557
918 975 -66 388 905 735 671 947 1,050 1,176 759 1,190 1,202 1,405 779 642 1,456 2,414 2,133 1,998 2,622 2,447 2,885 2,333 1,703 1,441 1,400 1,511 1,678 1,864 1,385 1,686 1,818 1,990 1,688 2,052 2,057 2,251 1,842 1,782 7,932
67 153 200 228 217 209 121 179 161 268 214 264 202 138 307 161 126 114 66 136 119 89 10 85 56 164 162 153 148 235 117 168 166 152 134 121 44 120 174 299 637
-179 875 736 295 626 574 431 777 718 947 632 1,102 1,103 1,240 633 526 1,421 2,388 2,043 1,348 2,493 2,327 2,876 2,352 1,758 1,320 1,562 1,636 1,671 1,795 1,436 1,607 1,940 2,030 1,778 2,150 2,180 2,358 1,449 1,524 7,511
178 110 350 25 65 1,438 22 59 166 292 -40 96 143 191 89 -11 189 230 250 159 393 338 429 334 323 287 244 261 235 201 211 305 294 -7,199 453 371 536 582 372 596 2,086
-329 798 419 283 603 -828 418 733 563 654 672 1,006 960 1,049 564 537 1,232 2,162 1,793 1,189 2,100 1,989 2,447 2,018 1,435 1,033 1,318 1,375 1,436 1,594 1,225 1,302 1,646 9,229 1,325 1,779 1,644 1,776 1,077 928 5,425
228 1,125 1,710 1,171 1,599 1,626 1,404 1,806 1,692 1,978 1,599 2,117 2,059 2,134 1,768 1,512 2,355 3,368 3,043 2,358 3,459 3,299 3,709 3,259 2,629 2,291 2,530 2,589 2,643 2,843 2,358 2,580 2,907 2,989 2,668 3,048 3,092 2,822 2,247 1,782 9,943

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?